{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:31:24Z","timestamp":1791901884082,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.maturitas.2018.07.016","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T12:35:12Z","timestamp":1533040512000},"page":"79-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase"],"prefix":"10.1016","volume":"116","author":[{"given":"Ulrike","family":"Sauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Talaulikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2018.07.016_bib0005","article-title":"Dehydroepiandrosterone for women in the peri- or postmenopausal phase","volume":"1","author":"Scheffers","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0010","article-title":"Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people","volume":"4","author":"Grimley Evans","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0015","article-title":"Dehydroepiandrosterone for systemic lupus erythematosus","volume":"4","author":"Crosbie","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0020","article-title":"Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction","volume":"11","author":"Nagels","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0025","article-title":"Testosterone for schizophrenia","volume":"3","author":"Elias","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0030","article-title":"Antiglucocorticoid and related treatments for psychosis","volume":"1","author":"Garner","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.maturitas.2018.07.016_bib0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.maturitas.2009.12.017","article-title":"DHEA for postmenopausal women: a review of the evidence","volume":"66","author":"Panjari","year":"2010","journal-title":"Maturitas"},{"issue":"October (10)","key":"10.1016\/j.maturitas.2018.07.016_bib0040","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1210\/jc.2014-2261","article-title":"The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis","volume":"99","author":"Elraiyah","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"June (6)","key":"10.1016\/j.maturitas.2018.07.016_bib0045","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1210\/jc.2010-2888","article-title":"DHEA replacement for postmenopausal women","volume":"96","author":"Davis","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"April","key":"10.1016\/j.maturitas.2018.07.016_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0055","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1111\/j.1743-6109.2011.02523.x","article-title":"Dehydroepiandrosterone (DHEA): a precursor steroid or an active hormone in human physiology","volume":"8","author":"Traish","year":"2011","journal-title":"J. Sex. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2018.07.016_bib0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9378(80)90912-6","article-title":"Total and free testosterone during pregnancy","volume":"137","author":"Bammann","year":"1980","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"November\u2013December (6)","key":"10.1016\/j.maturitas.2018.07.016_bib0065","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/gme.0b013e31803867a","article-title":"A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women","volume":"14","author":"Shifren","year":"2007","journal-title":"Menopause"},{"issue":"October (10)","key":"10.1016\/j.maturitas.2018.07.016_bib0070","first-page":"3558","article-title":"The zona reticularis is the site of biosynthesis of dehydroepinandrosterone and dehydroepinandrosterone sulfate in the adult adrenal cortex resulting from its low expression of 3\u03b2-hydroxysteroid dehydrogenase","volume":"81","author":"Endoh","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"March (3)","key":"10.1016\/j.maturitas.2018.07.016_bib0075","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jcem.86.3.7369","article-title":"Editorial: the role of androgens in women","volume":"86","author":"Snyder","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0080","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1210\/jc.2006-0284","article-title":"Circulating bioactive androgens in midlife women","volume":"91","author":"Chen","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5122(86)90025-3","article-title":"Steroid and gonadotropin levels in women during the perimenopausal years","volume":"8","author":"Longcope","year":"1986","journal-title":"Maturitas"},{"issue":"May\u2013August (3\u20134)","key":"10.1016\/j.maturitas.2018.07.016_bib0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0531-5565(94)90008-6","article-title":"Changes of ovarian hormonal function with aging","volume":"29","author":"Judd","year":"1994","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jsbmb.2014.06.001","article-title":"All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause","volume":"145","author":"Labrie","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001500.pub2","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"4","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004509.pub2","article-title":"Testosterone for peri- and postmenopausal women","author":"Somboonporn","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0110","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"8","author":"Lethaby","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2016.03.016","article-title":"Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks","volume":"159","author":"Martel","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.maturitas.2018.07.016_bib0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/hmbci-2015-0044","article-title":"Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study","volume":"25","author":"Bouchard","year":"2016","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"issue":"3","key":"10.1016\/j.maturitas.2018.07.016_bib0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GME.0000000000000571","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause","volume":"23","author":"Labrie","year":"2016","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.maturitas.2018.07.016_bib0130","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/GME.0000000000000428","article-title":"Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone","volume":"22","author":"Archer","year":"2015","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.maturitas.2018.07.016_bib0135","first-page":"39","article-title":"A low dose (6.5 mg) of intravaginal DHEA permits strictly local action while maintaining all serum oestrogens or androgens as well as their metabolites within normal values","volume":"29","author":"Labrie","year":"2017","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"4","key":"10.1016\/j.maturitas.2018.07.016_bib0140","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3109\/13697137.2014.992012","article-title":"Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy","volume":"18","author":"Bouchard","year":"2015","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.maturitas.2018.07.016_bib0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/hmbci-2015-0035","article-title":"Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA","volume":"24","author":"Ke","year":"2015","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jsbmb.2015.08.016","article-title":"Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration","volume":"154","author":"Ke","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.maturitas.2015.02.005","article-title":"Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study","volume":"81","author":"Labrie","year":"2015","journal-title":"Maturitas"},{"issue":"12","key":"10.1016\/j.maturitas.2018.07.016_bib0160","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/jsm.13045","article-title":"Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy","volume":"12","author":"Labrie","year":"2015","journal-title":"J. Sex. Med."},{"issue":"7","key":"10.1016\/j.maturitas.2018.07.016_bib0165","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/jsm.12517","article-title":"Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women","volume":"11","author":"Labrie","year":"2014","journal-title":"J. Sex. Med."},{"issue":"12","key":"10.1016\/j.maturitas.2018.07.016_bib0170","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/GME.0000000000000470","article-title":"Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women","volume":"22","author":"Portman","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2018.07.016_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2017.03.014","article-title":"Comparison of intravaginal 6.5Mg (0.50%) prasterone, 0.3Mg conjugated oestrogens and 10mcg estradiol on symptoms of vulvovaginal atrophy","author":"Archer","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.maturitas.2018.07.016_bib0180","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/13697137.2015.1077508","article-title":"Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner","volume":"18","author":"Labrie","year":"2015","journal-title":"Climacteric"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512218301816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512218301816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:12:57Z","timestamp":1759914777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512218301816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":36,"alternative-id":["S0378512218301816"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2018.07.016","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2018.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}